Lastly, CYR61 expression is linked to chemoresistance, particularly in triple-negative breast cancer, where it upregulates survivin expression and activates Wnt/β-catenin signaling, making cancer cells more resistant to chemotherapy [23] (Figure 1). The gene discussed is CCN1; the disease is cancer.